CAPRICOR THERAPEUTICS, INC. Guarantees, Fair Value Disclosure
CAPRICOR THERAPEUTICS, INC. (CAPR) had Guarantees, Fair Value Disclosure of $232.80 thousand as of 2019-01-11, per its 10-Q filed 2019-11-08.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:GuaranteesFairValueDisclosure · last filed 2019-11-08
- 2019-01-11: Guarantees, Fair Value Disclosure $232.80K.
| Period end | Guarantees, Fair Value Disclosure |
|---|---|
| 2019-01-11 | $232.80K 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |